Completed targets include prostaglandin analogue Tafluprost, the natural product isoanabasine, the antipsychotic preclamol and the recently approved anticancer agent Niraparib as well as fragrances phenoxanol and hyroxycitronellal.
Org. Lett. 2020, 22, 2991-2994.